Miwee Biology-B(02493): The offering price is determined to be HKD 27.64 per share.
Maiwei Biotech-B (02493) announced that the offering price for the sale of shares has been fixed at HK$27.64 per share on April 24, 2026.
Maiweibio-B (02493) announced that the offer price for the issuance was fixed at HKD 27.64 per share on April 24, 2026.
Assuming the global offer becomes unconditional by 8:00 am on April 28, 2026 (Tuesday) (Hong Kong time), it is expected that H shares will begin trading on the Main Board of the Stock Exchange of Hong Kong at 9:00 am on April 28, 2026 (Tuesday) (Hong Kong time). The trading unit for H shares will be 200 shares per lot.
Related Articles
CITIC SEC (06030) reported a net profit attributable to the parent of RMB 10.216 billion in the first quarter, representing a year-on-year increase of 54.6%.
ON April 24th, Ausnutria (01717) spent 499,300 Hong Kong dollars to repurchase 287,000 shares.
TENFU (06868) spent 8600 Hong Kong dollars to repurchase 3000 shares on April 24th.
CITIC SEC (06030) reported a net profit attributable to the parent of RMB 10.216 billion in the first quarter, representing a year-on-year increase of 54.6%.
ON April 24th, Ausnutria (01717) spent 499,300 Hong Kong dollars to repurchase 287,000 shares.
TENFU (06868) spent 8600 Hong Kong dollars to repurchase 3000 shares on April 24th.
RECOMMEND
The Great Transformation Of The Hong Kong Automotive Market
23/04/2026
Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026
Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026
